MENU
ANVS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Annovis Bio (ANVS) Ownership - Who owns Annovis Bio?
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases... Show more
Profile
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.77M
P/E Ratio
N/A
Total Cash
10.55M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash/Share
0.54
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANVS
Capitalization
23.8M
P/E Ratio
N/A
Risk (Beta)
1.53
Dividend Yield
N/A
Total Cash
10.6M
Total Cash/Share
0.54
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
9.31M
P/B Ratio
2.55
Cash Flow
N/A
Earnings
-2.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.41K
Current Ratio
3.59
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-26.69M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-203.78
Shares Held By Institutions
10.1M
Shares Outstanding - Current
19.5M
Total Liabilities
4.62M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-75.746
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
101 Lindenwood Drive
Phone
+1 484 875-3192
Employees
6
Web
https://www.annovisbio.com